Inspire Medical Systems Operating Income 2017-2023 | INSP
- Inspire Medical Systems operating income for the quarter ending December 31, 2023 was $0.009B, a 2875.22% decline year-over-year.
- Inspire Medical Systems operating income for the twelve months ending December 31, 2023 was $-0.040B, a 15.38% decline year-over-year.
- Inspire Medical Systems annual operating income for 2023 was $-0.04B, a 15.38% decline from 2022.
- Inspire Medical Systems annual operating income for 2022 was $-0.048B, a 19.43% increase from 2021.
- Inspire Medical Systems annual operating income for 2021 was $-0.04B, a 29.1% decline from 2020.
Inspire Medical Systems Annual Operating Income (Millions of US $) |
|
---|---|
2023 | $-40 |
2022 | $-48 |
2021 | $-40 |
2020 | $-56 |
2019 | $-35 |
2018 | $-20 |
2017 | $-16 |
2016 | $-17 |
Inspire Medical Systems Quarterly Operating Income (Millions of US $) |
|
---|---|
2023-12-31 | $9 |
2023-09-30 | $-13 |
2023-06-30 | $-17 |
2023-03-31 | $-19 |
2022-12-31 | $-0 |
2022-09-30 | $-17 |
2022-06-30 | $-14 |
2022-03-31 | $-16 |
2021-12-31 | $-2 |
2021-09-30 | $-10 |
2021-06-30 | $-13 |
2021-03-31 | $-16 |
2020-12-31 | $-7 |
2020-09-30 | $-10 |
2020-06-30 | $-23 |
2020-03-31 | $-16 |
2019-12-31 | $-9 |
2019-09-30 | $-9 |
2019-06-30 | $-8 |
2019-03-31 | $-9 |
2018-12-31 | $-5 |
2018-09-30 | $-5 |
2018-06-30 | $-6 |
2018-03-31 | $-5 |
2017-12-31 | $-4 |
2017-09-30 | $-4 |
2017-06-30 | $-4 |
2017-03-31 | $-4 |
2016-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $7.322B | $0.625B |
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $34.790B | 19.11 |
10x Genomics (TXG) | United States | $3.489B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.410B | 0.00 |
Axonics (AXNX) | United States | $3.396B | 0.00 |
Enovis (ENOV) | United States | $3.029B | 23.01 |
Azenta (AZTA) | United States | $2.925B | 238.46 |
Olink Holding AB (publ) (OLK) | Sweden | $2.864B | 0.00 |
Hims & Hers Health (HIMS) | United States | $2.685B | 0.00 |
Privia Health (PRVA) | United States | $2.183B | 96.84 |
Schrodinger (SDGR) | United States | $1.763B | 0.00 |
Omnicell (OMCL) | United States | $1.231B | 30.12 |
Phreesia (PHR) | United States | $1.169B | 0.00 |
Definitive Healthcare (DH) | United States | $0.817B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.783B | 0.00 |
Standard BioTools (LAB) | United States | $0.719B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.608B | 0.00 |
Talkspace (TALK) | United States | $0.519B | 0.00 |
Health Catalyst (HCAT) | United States | $0.367B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.333B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.312B | 0.00 |
Pulmonx (LUNG) | United States | $0.293B | 0.00 |
P3 Health Partners (PIII) | United States | $0.170B | 0.00 |
Butterfly Network (BFLY) | United States | $0.162B | 0.00 |
American Well (AMWL) | United States | $0.148B | 0.00 |
MSP Recovery (LIFW) | United States | $0.139B | 0.00 |
Augmedix (AUGX) | United States | $0.133B | 0.00 |
Outset Medical (OM) | United States | $0.131B | 0.00 |
TruBridge (TBRG) | United States | $0.116B | 4.94 |
111 (YI) | China | $0.087B | 0.00 |
Future Health ESG (FHLT) | United States | $0.073B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.071B | 0.00 |
HeartBeam (BEAT) | United States | $0.053B | 0.00 |
Zepp Health (ZEPP) | China | $0.052B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.047B | 0.00 |
Movano (MOVE) | United States | $0.044B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
Akili (AKLI) | United States | $0.031B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.025B | 0.00 |
Cue Health (HLTH) | United States | $0.022B | 0.00 |
CareCloud (CCLD) | United States | $0.018B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.018B | 0.00 |
ETAO (ETAO) | United States | $0.016B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
Biotricity (BTCY) | United States | $0.013B | 0.00 |
Transgenomic (PRPO) | United States | $0.008B | 0.00 |
HeartSciences (HSCS) | United States | $0.006B | 0.00 |
Syra Health (SYRA) | United States | $0.006B | 0.00 |
Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |